Elizabeth O’Day

Elizabeth O’Day

Company: Olaris Therapeutics

Job title: Founder & CEO


Dr. Elizabeth O’Day is the CEO and Founder of Olaris, Inc., a precision medicine company that uses metabolomics and proprietary machine learning algorithms to build patient stratification tools to fundamentally improve how disease is treated. Dr. O’Day is also the co-chair of the World Economic Forum’s Global Future Council on Biotechnology and serves on the advisory board for the Precision Medicine Initiative. Dr. O’Day received her PhD from Harvard University, where she was a National Science Foundation fellow. She was awarded a Winston Churchill fellowship and received a Master’s of Philosophy in Chemistry from the University of Cambridge. She has a Bachelor of Science degree from Boston College in Biochemistry. 


Panel Discussion: Women & Diversity in Precision Medicine 9:30 am

• Understanding the importance of female advocacy in the workplace • Adopting a female support system • Entering a post-COVID world: Building diverse teams and maximizing business creativity • Recognising the female leads in the pandemic response • Exploring HR metrics and laws surrounding salary renegotiation • Actioning changes: How the entire community can make…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.